Bayer Cropscience Performance
- Today's Low
- ₹4,474
- Today's High
- ₹4,670
- 52 Week Low
- ₹4,273
- 52 Week High
- ₹6,511
- Open Price₹4,669
- Previous Close₹4,616
- Volume37,890
- 50 DMA₹4,563.97
- 100 DMA₹4,619.97
- 200 DMA₹4,778.76
Bayer Cropscience Chart
Investment Returns
- Over 1 Month -1.98%
- Over 3 Month -3.49%
- Over 6 Month -3.2%
- Over 1 Year -21.1%
Smart Investing Starts Here Start SIP with Bayer Cropscience for Steady Growth!
Bayer Cropscience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.4
- PEG Ratio
- 1.4
- Market Cap Cr
- 20,267
- P/B Ratio
- 6.3
- Average True Range
- 120.12
- EPS
- 153.35
- Dividend Yield
- 2.8
- MACD Signal
- -73.26
- RSI
- 49.42
- MFI
- 51.92
Latest Stock News Updates
Revenues from operations for the quarter were up 5% at 1100 crore as compared to corresponding last quarter's 1046 crore
- Business Line
- 3 days 7 hours ago
Agrochemicals company Bayer Cropscience announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations: The company reported revenue of Rs 11,008 million for Q4FY26, representing a marginal decrease of 0.49% on a QoQ basis compared to Rs 11,062 million in Q3FY26, but an increase of 5.20% on a YoY basis compared to Rs 10,464 million in Q4FY25. For the full year FY26, revenue stood at Rs 56,750 million, up 3.68% from Rs 54,734 million in FY25. Total Income: For Q4FY26, total income was Rs 11,474 million, up 2.25% QoQ from Rs 11,221 million and up 5.90% YoY from Rs 10,835 million. The annual total income for FY26 reached Rs 57,700 million, a growth of 3.16% over FY25. Profit Before Tax (PBT): The company achieved a PBT of Rs 2,064 million in Q4FY26, showing a significant growth of 82.65% on a QoQ basis from Rs 1,130 million and an increase of 22.93% on a YoY basis from Rs 1,679 million. The annual PBT for FY26 was Rs 8,549 million, up 20.85% from Rs 7,074 million in FY25. Net Profit: Net profit for Q4FY26 stood at Rs 1,621 million, an increase of 69.38% QoQ from Rs 957 million and a 13.12% increase YoY from Rs 1,433 million. For the full year FY26, net profit was Rs 6,892 million, marking a 21.34% growth compared to Rs 5,680 million in FY25. Total Comprehensive Income: The total comprehensive income for Q4FY26 was Rs 1,539 million. For the full year FY26, it reached Rs 6,771 million, representing a 20.31% increase from Rs 5,628 million in FY25. Dividend: The Board of Directors has recommended a final dividend of Rs 60/- per share for the year ended March 31, 2026, amounting to Rs 2,697 million for 44,942,092 equity shares of Rs 10/- each. Earnings Per Share (EPS): Basic and diluted EPS for FY26 stood at Rs 153.35, compared to Rs 126.38 in FY25. Business Highlights: Segment Performance: The company operates in a single reportable business segment, "Agri Care." Seasonality: The company noted that its business is seasonal in nature, and therefore, quarterly figures are not necessarily representative of the full year's performance. Impact of New Labour Codes: Based on the information available as at March 31, 2026, the company assessed that the incremental impact of the "New Labour Codes" on employee benefit obligations is not material. Discontinued Operations: During the previous year (FY25), the company had sold its Energy Undertaking (57 MW captive wind power plant) on a slump-sale basis for Rs 200 crore. Simon Wiebusch, Vice Chairman & Managing Director and CEO, BCSL, said: “In Q4, we delivered a resilient performance, with revenue growing ~5%, reflecting the underlying strength of our business in a challenging environment, even as growth moderated versus our ambitions. While corn saw a softer season, our diversified portfolio sustained momentum. Our full-year performance remained measured, shaped by Kharif disruptions and a deliberate focus on disciplined channel management and long-term value creation over short-term volume acceleration. We remain well-positioned to drive sustainable, quality-led growth going forward.” Vinit Jindal, Executive Director & Chief Financial Officer, BCSL, said: “Profit After Tax grew by 21% for the full year. Amidst external challenges, the Company maintained financial stability through disciplined cost and cash flow management. The balance sheet remains strong providing flexibility to support operations and strategic priorities. We continue to focus on driving profitable growth and maintaining balance-sheet resilience.” Result PDF
- Trendlyne
- 3 days 9 hours ago
Xabi Alonso is set to be named Chelsea coach after reaching an agreement with the Premier League club, a person with knowledge of the situation told the Associated Press on Saturday. The person spoke on condition of anonymity because the appointment has not been publicly announced. Alonso talked with Chelsea in the past week and is expected to sign a four-year contract. It would be the Spaniard's first job since lasting less than eight months at Real Madrid. Alonso left Madrid by mutual consent in January after poor results and widespread media reports that he lost control of the locker room. Despite the short tenure at the Bernabeu Stadium, Alonso's reputation remained high across Europe after leading Bayer Leverkusen to a German league and cup double and breaking Bayern Munich's dominance of the Bundesliga. Chelsea has been searching for a new coach since firing Liam Rosenior last month. Rosenior was the second coach to be fired since the turn of the year following the departur
- Business Standard
- 1 week 5 days ago
Bayer Cropscience Financials
Bayer Cropscience Technicals
EMA & SMA
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹4,492.72
- 50 Day
- ₹4,563.97
- 100 Day
- ₹4,619.97
- 200 Day
- ₹4,778.76
Resistance and Support
- R3 4,824.60
- R2 4,747.30
- R1 4,628.40
- S1 4,432.20
- S2 4,354.90
- S3 4,236.00
Bayer Cropscience Corporate Actions - Bonus, Splits, Dividends
About Bayer Cropscience
- NSE Symbol
- BAYERCROP
- BSE Symbol
- 506285
- ISIN
- INE462A01022
Similar Stocks to Bayer Cropscience
Popular Stocks
Bayer Cropscience FAQs
Bayer Cropscience share price is ₹4,509 As on 30 May, 2026 | 04:02
The Market Cap of Bayer Cropscience is ₹20266.6 Cr As on 30 May, 2026 | 04:02
The P/E ratio of Bayer Cropscience is 29.4 As on 30 May, 2026 | 04:02
The PB ratio of Bayer Cropscience is 6.3 As on 30 May, 2026 | 04:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.